• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力研究揭示了 tau 包涵体的快速形成和可观的周转率。

Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions.

机构信息

Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.

Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.

出版信息

Acta Neuropathol. 2021 Mar;141(3):359-381. doi: 10.1007/s00401-021-02264-9. Epub 2021 Jan 26.

DOI:10.1007/s00401-021-02264-9
PMID:33496840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7882582/
Abstract

Accumulation of the tau protein in fibrillar intracellular aggregates is a defining feature of multiple neurodegenerative diseases collectively referred to as tauopathies. Despite intensive study of tau, there is limited information on the formation and clearance dynamics of tau inclusions. Using rAAV vectors to mediate expression of Dendra2-tagged human wild-type, P301L and pro-aggregant P301L/S320F tau proteins, with and without the addition of exogenous tau fibrillar seeds, we evaluated tau inclusion dynamics in organotypic brain slice culture (BSC) models using long-term optical pulse labeling methodology. Our studies reveal that tau inclusions typically form in 12-96 h in tauopathy BSC models. Unexpectedly, we demonstrate appreciable turnover of tau within inclusions with an average half-life of ~ 1 week when inclusions are newly formed. When BSCs with inclusions are aged in culture for extended periods, tau inclusions continue to turnover, but their half-lives increase to ~ 2 weeks and ~ 3 weeks after 1 and 2 months in culture, respectively. Individual tau inclusions can be long-lived structures that can persist for months in these BSC models and for even longer in the human brain. However, our data indicate that tau inclusions, are not 'tombstones', but dynamic structures with appreciable turnover. Understanding the cellular processes mediating this inclusion turnover may lead to new therapeutic strategies that could reverse pathological tau inclusion formation.

摘要

tau 蛋白在纤维状细胞内聚集体中的积累是多种神经退行性疾病的一个特征,这些疾病统称为 tau 病。尽管对 tau 进行了深入研究,但关于 tau 包含物的形成和清除动力学的信息有限。我们使用 rAAV 载体介导表达 Dendra2 标记的人野生型、P301L 和促聚集 P301L/S320F tau 蛋白,同时添加和不添加外源性 tau 纤维状种子,使用长期光学脉冲标记方法在器官型脑切片培养 (BSC) 模型中评估 tau 包含物的动力学。我们的研究表明,tau 包含物通常在 tau 病 BSC 模型中形成 12-96 小时。出乎意料的是,我们证明了在包含物中 tau 的周转率相当高,当包含物是新形成时,平均半衰期约为 1 周。当含有包含物的 BSCs 在培养中老化延长时间时,tau 包含物仍在不断周转,但它们的半衰期分别增加到培养 1 个月和 2 个月后约 2 周和 3 周。单个 tau 包含物可以是长期存在的结构,可以在这些 BSC 模型中持续数月,甚至在人类大脑中持续更长时间。然而,我们的数据表明,tau 包含物不是“墓碑”,而是具有相当周转率的动态结构。了解介导这种包含物周转率的细胞过程可能会导致新的治疗策略,从而逆转病理性 tau 包含物的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/93bb20eeeda5/401_2021_2264_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/68340eb71d6b/401_2021_2264_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/2094ad330ccb/401_2021_2264_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/6a8310baa46c/401_2021_2264_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/b147f4181078/401_2021_2264_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/475927d4902a/401_2021_2264_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/a94ca94c4a46/401_2021_2264_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/a3a086cef5aa/401_2021_2264_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/4dec08729920/401_2021_2264_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/93bb20eeeda5/401_2021_2264_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/68340eb71d6b/401_2021_2264_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/2094ad330ccb/401_2021_2264_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/6a8310baa46c/401_2021_2264_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/b147f4181078/401_2021_2264_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/475927d4902a/401_2021_2264_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/a94ca94c4a46/401_2021_2264_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/a3a086cef5aa/401_2021_2264_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/4dec08729920/401_2021_2264_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e0/7882582/93bb20eeeda5/401_2021_2264_Fig9_HTML.jpg

相似文献

1
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions.光动力研究揭示了 tau 包涵体的快速形成和可观的周转率。
Acta Neuropathol. 2021 Mar;141(3):359-381. doi: 10.1007/s00401-021-02264-9. Epub 2021 Jan 26.
2
Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.小热休克蛋白αB-晶状体蛋白在伴有胶质病理改变的tau蛋白病中的表达。
Am J Pathol. 2004 Jan;164(1):155-66. doi: 10.1016/s0002-9440(10)63106-9.
3
Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice.rTg4510 小鼠的相互 F1 杂种之间 tau 病理学的差异积累。
Sci Rep. 2021 May 5;11(1):9623. doi: 10.1038/s41598-021-89142-2.
4
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.转谷氨酰胺酶 1 和其调节剂他扎罗汀诱导基因 3 在神经原纤维缠结tau 病中定位于神经元 tau 包涵体。
J Pathol. 2012 Jan;226(1):132-42. doi: 10.1002/path.2984. Epub 2011 Oct 18.
5
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.新的特异性单克隆抗体证实,tau蛋白病中的病理性包涵体含有具有三个或四个微管结合重复结构域的不同tau蛋白互补物。
Neuropathol Appl Neurobiol. 2003 Jun;29(3):288-302. doi: 10.1046/j.1365-2990.2003.00463.x.
6
Tau exhibits unique seeding properties in globular glial tauopathy.Tau 在球形神经胶质朊病毒病中表现出独特的成核特性。
Acta Neuropathol Commun. 2019 Mar 7;7(1):36. doi: 10.1186/s40478-019-0691-9.
7
Analysis of in vivo turnover of tau in a mouse model of tauopathy.在tau蛋白病小鼠模型中tau蛋白的体内周转分析。
Mol Neurodegener. 2015 Oct 26;10:55. doi: 10.1186/s13024-015-0052-5.
8
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.tau蛋白酪氨酸磷酸化的增加与tau蛋白聚集体的形成相关。
Brain Res Mol Brain Res. 2005 Aug 18;138(2):135-44. doi: 10.1016/j.molbrainres.2005.04.015.
9
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.人源tau 病相关 tau 株决定了被招募用于模板扩增的底物。
Brain. 2021 Sep 4;144(8):2333-2348. doi: 10.1093/brain/awab091.
10
Cellular and pathological heterogeneity of primary tauopathies.原发性 tau 病的细胞和病理学异质性。
Mol Neurodegener. 2021 Aug 23;16(1):57. doi: 10.1186/s13024-021-00476-x.

引用本文的文献

1
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function.利用模板化聚集物来降解致病的 tau 聚集体并改善运动功能。
Cell. 2024 Oct 17;187(21):5967-5980.e17. doi: 10.1016/j.cell.2024.08.024. Epub 2024 Sep 13.
2
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease.探讨针对阿尔茨海默病的tau 靶向治疗药物的临床试验中生物标志物策略的考虑因素。
Transl Neurodegener. 2024 May 21;13(1):25. doi: 10.1186/s40035-024-00417-w.
3
Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions.

本文引用的文献

1
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes.靶向细胞质或分泌途径的抗 tau scFv 可变地修饰病理学和神经退行性表型。
Mol Ther. 2021 Feb 3;29(2):859-872. doi: 10.1016/j.ymthe.2020.10.007. Epub 2020 Oct 14.
2
Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.利用最小纯化的分泌型 rAAV 在中枢神经系统中快速且经济有效地操纵基因表达。
Mol Neurodegener. 2020 Mar 2;15(1):15. doi: 10.1186/s13024-020-00361-z.
3
Organotypic brain slice cultures to model neurodegenerative proteinopathies.
类淋巴/脑膜淋巴系统在阿尔茨海默病中的作用:对蛋白质稳态的见解及未来方向
Cell Mol Life Sci. 2024 Apr 23;81(1):192. doi: 10.1007/s00018-024-05225-z.
4
Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans.转基因 Dendra2::tau 表达可在秀丽隐杆线虫体内监测 tau 的蛋白稳态。
Dis Model Mech. 2024 Mar 1;17(3). doi: 10.1242/dmm.050473. Epub 2024 Mar 28.
5
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.脑脊液 Tau 微管结合区的变化可检测到显性遗传性阿尔茨海默病的症状发作、认知下降、缠结和萎缩。
Ann Neurol. 2023 Jun;93(6):1158-1172. doi: 10.1002/ana.26620. Epub 2023 Mar 16.
6
Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance.光脉冲标记研究表明外源性种子减缓了α-突触核蛋白的清除。
NPJ Parkinsons Dis. 2022 Dec 19;8(1):173. doi: 10.1038/s41531-022-00434-4.
7
Intraneuronal tau aggregation induces the integrated stress response in astrocytes.神经细胞内 tau 聚集诱导星形胶质细胞的综合应激反应。
J Mol Cell Biol. 2023 Mar 29;14(10). doi: 10.1093/jmcb/mjac071.
8
Cortical waste clearance in normal and restricted sleep with potential runaway tau buildup in Alzheimer's disease.正常和限制睡眠下的皮质废物清除与阿尔茨海默病中潜在失控的 tau 积聚。
Sci Rep. 2022 Aug 12;12(1):13740. doi: 10.1038/s41598-022-15109-6.
9
Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice.致病tau 招募野生型 tau 进入脑内包涵体,并在转基因 SPAM 小鼠中诱导肠道退化。
Commun Biol. 2022 May 12;5(1):446. doi: 10.1038/s42003-022-03373-1.
10
Parallel gold enhancement of quantum dots 565/655 for double-labelling correlative light and electron microscopy on human autopsied samples.用于人体尸检样本的相关光镜和电子显微镜双标记的量子点 565/655 的金颗粒平行增强。
Sci Rep. 2022 Apr 12;12(1):6113. doi: 10.1038/s41598-022-09849-8.
器官型脑切片培养物用于模拟神经退行性蛋白构象病。
Mol Neurodegener. 2019 Dec 2;14(1):45. doi: 10.1186/s13024-019-0346-0.
4
Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.同时携带 P301L 和 S320F 突变的 tau 蛋白可产生新型的 tau 病加速模型。
Hum Mol Genet. 2019 Oct 1;28(19):3255-3269. doi: 10.1093/hmg/ddz151.
5
rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologies.基于 rAAV 的阿尔茨海默病和帕金森病包涵体病大脑切片培养模型。
J Exp Med. 2019 Mar 4;216(3):539-555. doi: 10.1084/jem.20182184. Epub 2019 Feb 15.
6
Alzheimer's disease: The right drug, the right time.阿尔茨海默病:选对药物,把握时机。
Science. 2018 Dec 14;362(6420):1250-1251. doi: 10.1126/science.aau0437.
7
Animal models of neurodegenerative diseases.神经退行性疾病的动物模型。
Nat Neurosci. 2018 Oct;21(10):1370-1379. doi: 10.1038/s41593-018-0236-8. Epub 2018 Sep 24.
8
Preparation of organotypic brain slice cultures for the study of Alzheimer's disease.用于阿尔茨海默病研究的器官型脑片培养物的制备
F1000Res. 2018 May 15;7:592. doi: 10.12688/f1000research.14500.2. eCollection 2018.
9
Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.针对人 tau 微管结合域的新型单克隆抗体。
PLoS One. 2018 Apr 2;13(4):e0195211. doi: 10.1371/journal.pone.0195211. eCollection 2018.
10
Tau Kinetics in Neurons and the Human Central Nervous System.神经元和人中枢神经系统中的 Tau 动力学。
Neuron. 2018 Mar 21;97(6):1284-1298.e7. doi: 10.1016/j.neuron.2018.02.015.